Hypertension Diagnostics (OTCMKTS:HDII) Stock Price Up 50%

Hypertension Diagnostics, Inc. (OTCMKTS:HDII)’s stock price rose 50% during mid-day trading on Monday . The stock traded as high as $0.02 and last traded at $0.02, approximately 12,498,945 shares changed hands during mid-day trading. An increase of 132% from the average daily volume of 5,388,989 shares. The stock had previously closed at $0.02.

The company has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.01.

About Hypertension Diagnostics (OTCMKTS:HDII)

Hypertension Diagnostics, Inc designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease.

See Also: Dividend

Receive News & Ratings for Hypertension Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypertension Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.